Common Contracts
5 similar Registration Rights Agreement contracts by Venus Concept Inc., EyePoint Pharmaceuticals, Inc., pSivida Corp., SELLAS Life Sciences Group, Inc.
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • November 7th, 2019 • Venus Concept Inc. • Surgical & medical instruments & apparatus • Delaware
This REGISTRATION RIGHTS AGREEMENT (as it may be amended from time to time in accordance with the terms hereof, the “Agreement”), dated as of November 7, 2019, is made by and among Venus Concept Inc. (formerly named Restoration Robotics, Inc. (“Restoration Robotics”)), a Delaware corporation (the “Company”) and the investors listed on Schedule I hereto (together with their Permitted Transferees that become party hereto, the “Investors”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • November 7th, 2019 • Venus Concept Inc. • Surgical & medical instruments & apparatus • New York
This REGISTRATION RIGHTS AGREEMENT (as it may be amended from time to time in accordance with the terms hereof, the “Agreement”), dated as of November 7, 2019, is made by and among Venus Concept Inc. (formerly named Restoration Robotics, Inc. (“Restoration Robotics”)), a Delaware corporation (the “Company”), and the investors listed on Schedule I hereto (together with their Permitted Transferees that become party hereto, the “Investors”). Terms that are not defined herein, shall have the meaning set forth in the Stock Purchase Agreement (as defined below).
ContractRegistration Rights Agreement • June 27th, 2018 • EyePoint Pharmaceuticals, Inc. • Laboratory analytical instruments • New York
This SECOND REGISTRATION RIGHTS AGREEMENT (as it may be amended from time to time in accordance with the terms hereof, the “Agreement”), dated as of June 25, 2018, is made by and among EyePoint Pharmaceuticals, Inc., a Delaware corporation (the “Company”) and EW Healthcare Partners L.P., EW Healthcare Partners-A L.P. and each other Person identified on the signature pages hereto as an “Investor” (together with their Permitted Transferees that become party hereto, the “Investors”).
ContractRegistration Rights Agreement • May 15th, 2018 • SELLAS Life Sciences Group, Inc. • Pharmaceutical preparations • New York
This REGISTRATION RIGHTS AGREEMENT (as it may be amended from time to time in accordance with the terms hereof, the “Agreement”), dated as May 14, 2018, is made by and among SELLAS Life Sciences Group, Inc., a Delaware corporation (the “Company”) and Equilibria Capital Management Limited, a Bermuda limited liability company; EQC Private Markets SAC Fund II Ltd-EQC Biotech Sely S Fund, a Bermuda mutual fund company; EQC Private Markets SAC Fund Ltd-EQC Biotech Sely I Fund, a Bermuda mutual fund company; EQC Private Markets SAC Fund Ltd-EQC Biotech Sely II Fund, a Bermuda mutual fund company; EQC Private Markets II SAC Fund Ltd-EQC Biotech Sely III Fund, a Bermuda mutual fund company; and Varibobi Financial Holdings Ltd., a Cyprus limited company and Daniel Tafur, an individual (together with their Permitted Transferees that become party hereto, the “Investors”).
ContractRegistration Rights Agreement • March 29th, 2018 • pSivida Corp. • Laboratory analytical instruments • New York
This REGISTRATION RIGHTS AGREEMENT (as it may be amended from time to time in accordance with the terms hereof, the “Agreement”), dated as of March 28, 2018, is made by and among pSivida Corp., a Delaware corporation (the “Company”) and EW Healthcare Partners L.P. and EW Healthcare Partners-A L.P. (together with their Permitted Transferees that become party hereto, the “Investors”).
